Share Price Movement

RNS Number : 6099S

Integumen PLC

12 March 2019

 

AIM Share Code: SKIN

12 March 2019

Integumen PLC

("Integumen" or "Company")

Share Price Movement

Integumen has noted the increase in the price of the shares of the Company over recent days.

The transformation of the Company has been swift since new management took over in August 2018.This is evident from the content of trading updates, recent laboratory expansion and CBD test results from the Company's Labskin Eco-System. Part of Integumen's growth strategy involves actively pursuing a broader portfolio of services, that contribute to increased revenues per client, through existing revenue shared collaboration and acquisition options that include, data analytics, software and biophysics integration services.

The Company is currently involved in a number of such discussions that may or may not lead to further accelerated expansion of the Company portfolio. Integumen will update the market with any new material information as appropriate in line with regulatory disclosure requirements.

Contacts

Integumen plc	Gerard Brandon, CEO	[phone]
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Hybridan LLP  (Broker)	Claire Noyce	[phone]

About Integumen:

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

 

END

 

 

SPMLLFSIVAIFLIA